344 related articles for article (PubMed ID: 26162286)
1. Cardiovascular disease associated with human immunodeficiency virus: a review.
Costa LA; Almeida AG
Rev Port Cardiol; 2015; 34(7-8):479-91. PubMed ID: 26162286
[TBL] [Abstract][Full Text] [Related]
2. Reviewing the cardiovascular complications of HIV infection after the introduction of highly active antiretroviral therapy.
Barbaro G
Curr Drug Targets Cardiovasc Haematol Disord; 2005 Aug; 5(4):337-43. PubMed ID: 16101566
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular disease and toxicities related to HIV infection and its therapies.
Zareba KM; Miller TL; Lipshultz SE
Expert Opin Drug Saf; 2005 Nov; 4(6):1017-25. PubMed ID: 16255661
[TBL] [Abstract][Full Text] [Related]
4. Highly active antiretroviral therapy-associated metabolic syndrome and cardiovascular risk.
Barbaro G; Barbarini G
Chemotherapy; 2006; 52(4):161-5. PubMed ID: 16675900
[TBL] [Abstract][Full Text] [Related]
5. [HIV infection: emerging issues and new challenges].
Calza L; Manfredi R; Chiodo F
Recenti Prog Med; 2006 Dec; 97(12):771-80. PubMed ID: 17252736
[TBL] [Abstract][Full Text] [Related]
6. Endothelial and platelet function alterations in HIV-infected patients.
Gresele P; Falcinelli E; Sebastiano M; Baldelli F
Thromb Res; 2012 Mar; 129(3):301-8. PubMed ID: 22192157
[TBL] [Abstract][Full Text] [Related]
7. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
8. The effects of highly active antiretroviral therapy on albuminuria in HIV-infected persons: results from a randomized trial.
Gupta SK; Parker RA; Robbins GK; Dubé MP
Nephrol Dial Transplant; 2005 Oct; 20(10):2237-42. PubMed ID: 16105869
[TBL] [Abstract][Full Text] [Related]
9. Risk of premature atherosclerosis and ischemic heart disease associated with HIV infection and antiretroviral therapy.
Calza L; Manfredi R; Pocaterra D; Chiodo F
J Infect; 2008 Jul; 57(1):16-32. PubMed ID: 18358535
[TBL] [Abstract][Full Text] [Related]
10. Highly active antiretroviral therapy and cardiovascular complications in HIV-infected patients.
Barbaro G; Klatt EC
Curr Pharm Des; 2003; 9(18):1475-81. PubMed ID: 12769727
[TBL] [Abstract][Full Text] [Related]
11. Metabolic and skeletal complications of HIV infection: the price of success.
Morse CG; Kovacs JA
JAMA; 2006 Aug; 296(7):844-54. PubMed ID: 16905789
[TBL] [Abstract][Full Text] [Related]
12. [Pulmonary hypertension in human immunodeficiency virus-infected patients: the role of antiretroviral therapy].
Olalla J; Urdiales D; Pombo M; del Arco A; de la Torre J; Prada JL
Med Clin (Barc); 2014 Mar; 142(6):248-52. PubMed ID: 23490486
[TBL] [Abstract][Full Text] [Related]
13. Dyslipidaemia and cardiovascular risk in HIV infection.
Kulasekaram R; Peters BS; Wierzbicki AS
Curr Med Res Opin; 2005 Nov; 21(11):1717-25. PubMed ID: 16307691
[TBL] [Abstract][Full Text] [Related]
14. Serum lipid levels associated with increased risk for cardiovascular disease is associated with highly active antiretroviral therapy (HAART) in HIV-1 infection.
Koppel K; Bratt G; Eriksson M; Sandström E
Int J STD AIDS; 2000 Jul; 11(7):451-5. PubMed ID: 10919487
[TBL] [Abstract][Full Text] [Related]
15. The basis and management of metabolic abnormalities associated with cardiovascular risk in human immunodeficiency virus infection and its treatment.
Crook M
Ann Clin Biochem; 2007 May; 44(Pt 3):219-31. PubMed ID: 17456292
[TBL] [Abstract][Full Text] [Related]
16. Management of metabolic complications and cardiovascular risk in HIV-infected patients.
Blanco F; San Román J; Vispo E; López M; Salto A; Abad V; Soriano V
AIDS Rev; 2010; 12(4):231-41. PubMed ID: 21179187
[TBL] [Abstract][Full Text] [Related]
17. Sepsis predisposition in children with human immunodeficiency virus.
Hatherill M
Pediatr Crit Care Med; 2005 May; 6(3 Suppl):S92-8. PubMed ID: 15857567
[TBL] [Abstract][Full Text] [Related]
18. [HIV infection, antiretroviral therapy, and endothelium].
Hürlimann D; Weber R; Enseleit F; Lüscher TF
Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
[TBL] [Abstract][Full Text] [Related]
19. HAART to heart: highly active antiretroviral therapy and the risk of cardiovascular disease in HIV-infected or exposed children and adults.
Lipshultz SE; Mas CM; Henkel JM; Franco VI; Fisher SD; Miller TL
Expert Rev Anti Infect Ther; 2012 Jun; 10(6):661-74. PubMed ID: 22734956
[TBL] [Abstract][Full Text] [Related]
20. HIV infection, antiretroviral therapy and cardiovascular risk.
Barbaro G
J Cardiovasc Risk; 2002 Oct; 9(5):295-300. PubMed ID: 12394324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
